Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Cilostazol on EPCs in High Risk CVD
NCT02194686Phase 4Completed
- Sponsor
- National Cheng Kung University Hospital
- Start
- Jan 2013
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in cardiovascular disease (CVD), sponsored by National Cheng Kung University Hospital. Started Jan 2013; status: completed.
02
Drugs
cilostazol
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02194686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194686.